CHICAGO Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to encourage development of new tests for early detection of Alzheimer's disease.
- China heart drug sold globally may have had impurity since 2012
- Judge rules for Trump administration in suit over family-planning program shift
- Teen suicide risk may be lower with intense team-based therapy
- Roche touts new flu drug as Tamiflu suffers generics hit
- Mylan signs U.S. license deal on Humira with AbbVie
(Reuters Health) - The 46 medicines given approval through 2017 as part of the U.S. Food and Drug Administration's Breakthrough Therapy program have often been sent to patients without a large double-blind study, direct measurement of benefit, or comparison with a placebo or existing treatment, according to a new analysis by researchers at Yale University and the Yale School of Medicine.
(Reuters Health) - The kind of imaging U.S. women receive after treatment for non-metastatic breast cancer can vary widely, a new study finds.
(Reuters Health) - Teens who spend lots of time surfing the web, playing games and chatting with friends on smartphones and tablets may be more likely to develop ADHD symptoms than youth who don’t, a U.S. study suggests.
Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent.